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Abstract
Objective: Deficiencies and excess of essential elements and toxic metals are
implicated in amyotrophic lateral sclerosis (ALS), but the age when metal dys-
regulation appears remains unknown. This study aims to determine whether
metal uptake is dysregulated during childhood in individuals eventually diag-
nosed with ALS. Methods: Laser ablation-inductively coupled plasma-mass
spectrometry was used to obtain time series data of metal uptake using
biomarkers in teeth from autopsies or dental extractions of ALS (n = 36) and
control (n = 31) participants. Covariate data included sex, smoking, occupa-
tional exposures, and ALS family history. Case–control differences were identi-
fied in temporal profiles of metal uptake for individual metals using distributed
lag models. Weighted quantile sum (WQS) regression was used for metals mix-
ture analyses. Similar analyses were performed on an ALS mouse model to fur-
ther verify the relevance of dysregulation of metals in ALS. Results: Metal levels
were higher in cases than in controls: 1.49 times for chromium (1.11–1.82; at
15 years), 1.82 times for manganese (1.34–2.46; at birth), 1.65 times for nickel
(1.22–2.01; at 8 years), 2.46 times for tin (1.65–3.30; at 2 years), and 2.46 times
for zinc (1.49–3.67; at 6 years). Co-exposure to 11 elements indicated that
childhood metal dysregulation was associated with ALS. The mixture contribu-
tion of metals to disease outcome was likewise apparent in tooth biomarkers of
an ALS mouse model, and differences in metal distribution were evident in
ALS mouse brains compared to brains from littermate controls. Interpretation:
Overall, our study reveals direct evidence that altered metal uptake during
specific early life time windows is associated with adult-onset ALS.
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Introduction
Amyotrophic lateral sclerosis (ALS) is a fatal disease
characterized by motor neuron degeneration and com-
plex pathogenesis.1 The gene-time-environment hypoth-
esis of ALS suggests that environmental exposures,
superimposed on genetic risk and aging, underlie the
pathogenesis of ALS.2 Metals are plausible risk factors
for ALS due to their role in biology and widespread
exposure.3 The extent to which metal toxicity pro-
motes late-onset neurodegeneration, however, depends
on exposure duration, developmental stage, metal toxi-
cokinetics, and interactive toxic mechanisms in metal
mixtures.4,5
While there is an urgent need to identify metal
exposures associated with ALS to improve our patho-
physiologic understanding and modify disease risk,
there are limitations in quantifying early life exposure
to metals using surveys or biofluids after disease onset.
The teeth are an attractive tissue to overcome these
limitations because of their unique developmental
properties. Deciduous (baby) teeth commence develop-
ment prenatally, and permanent (adult) teeth around
birth, growing in an incremental manner similar to
growth rings in trees.6 During mineralization, essential
nutrient elements and toxic metals that enter the
blood circulation after exposure or as part of normal
metabolism are captured in these chronological rings.
The growth rate of teeth is well known because teeth
undergo limited remodeling, except in the case of den-
tal caries or attrition, trace element deposits in teeth
are stable. Therefore, retrospective and accurate early
life metal uptake assessment is reliable.7,8
We have previously used laser ablation-inductively
coupled plasma-mass spectrometry (LA-ICP-MS) to
develop temporal profiles of metal exposure during
early development associated with mental health con-
ditions using deciduous teeth.9–13 This technique uses
a laser beam to scan along the growth trajectory of
the tooth and the ejected metal deposits are trans-
ferred to a mass-spectrometer for quantitative assess-
ment of metal content. Here, we refined this
technique to analyze permanent teeth of ALS partici-
pants and neurologically healthy controls. We uncov-
ered metal uptake differences between groups and
discrete developmental windows – postnatally to
approximately 15 years – when metals, individually
and in combination, are significantly associated with
ALS onset decades later. We further verified the rele-
vance of metal dysregulation in a transgenic mouse
model of ALS. This is the first study to retrospectively




ALS participants diagnosed in accordance with the revised
EI Escorial criteria14 were recruited from the University
of Michigan ALS Clinic. C9orf72 genotyping was per-
formed as previously reported15 and Cu2+/Zn2+ superox-
ide dismutase-1 (SOD1) genotyping was performed in a
CLIA-certified laboratory. Control participants undergo-
ing multiple teeth extractions were recruited at the
University of Michigan School of Dentistry. Adult partici-
pants and/or next of kin provided informed consent. This
research was approved by the University of Michigan
Institutional Review Board (#HUM00028826).
Sample collection and analyses for human
samples
Human permanent teeth were obtained at autopsy or
routine dental extractions. Metal concentrations were
determined by LA-ICP-MS.10 A New Wave Research
NWR-193 laser ablation unit (Electro Scientific Indus-
tries) with a 193 nm ArF excimer laser connected to an
Agilent Technologies 8800 triple-quad ICP-MS (Agilent
Technologies) was used. Helium was the carrier gas from
the laser ablation cell and was mixed with argon before
entering the ICP-MS via a Y-piece. Sensitivity (maximum
analyte ion counts), oxide formation (232Th16O+/232Th+,
< 0.3%), and fractionation (232Th+/238U+, 100  5%)
were monitored daily using NIST SRM 612 (trace ele-
ments in glass). The laser was scanned in dentine parallel
to the dentine-enamel junction from the dentine horn tip
toward the tooth cervix. A pre-ablation scan removed
surface contamination. Data were analyzed as metal
(metal studied) to calcium (internal standard) ratios to
control for variations in mineral content within a tooth
and between samples. Each tooth was sampled, on aver-
age, at over 5000 locations (Table 1). We performed an
untargeted scan and 11 metals were reliably detected in
our analysis – barium, chromium, copper, lead, lithium,
magnesium, manganese, nickel, strontium, tin, and zinc.
All are either essential elements or neurotoxic metals we
have previously analyzed.13 Other metals were not mea-
sured because they were either below detection limits
(e.g., aluminum and mercury) or because they are not
reliably detected by LA-ICP-MS (e.g., fluoride and iron).
Demographic differences in case and control partici-
pants were determined via chi-squared, Fisher’s exact, or
Student’s t-test. We applied a variant of distributed lag
models (DLMs) to identify specific time periods (birth to
15 years) when the above 11 individual metals were
differentially absorbed. DLMs adjust for past (lagged)
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exposures to identify differences in temporal profiles of
metal exposure between groups.16 Confidence intervals
(CIs), projected on the case–control divergence in metal
concentrations over time, identified critical periods by the
separation of model CIs from a zero boundary (critical
susceptibility window).17
Developmental windows associated with ALS and the
relative contribution to health outcome from exposure to
all metals jointly or individually were determined by
weighted quantile sum (WQS) regression. WQS is a penal-
ized regression technique that uses a nonnegative, unit-sum
constraint grouping variables into a unidimensional index.
Each variable of the index (metals) contributes to the index
value (0 and 1 or 1 and 0). The index emerges as a
weighted sum of the component variables, where the
weights are estimated empirically. Because the WQS regres-
sion estimates the individual and combined effects of met-
als on ALS at a prespecified time window, rather than the
entire time period studied, we used lagged WQS. Incorpo-
rating features of DLMs, the WQS index was calculated
over time while adjusting for past lagged values, resulting
in a “lagged” WQS.4,18,19 Lagged WQS identified time peri-
ods at which metals in a mixture were significantly different
between groups. We calculated 95% CIs to identify statisti-
cally significant periods of case–control differences and
applied Holm–Bonferroni corrections to adjust for multi-
ple comparison effects.16,20 A sensitivity analysis was per-
formed by removing subjects with a family history of ALS
or known genetic mutations. The type of tooth does not
impact the statistical models used.
ALS animal model, sample collection, and
analysis
Eight male and eight female hemizygous mice expressing
mutant human SOD1-G93A [B6.Cg-Tg(SOD1*G93A)1Gur/
J]21 (SOD1G93A) and 16 sex-matched wild-type (WT)
control littermates (JAX stock #004435; Jackson Laborato-
ries, Bar Harbor, Maine) were fed with a 5L0D rodent diet,
which contains chromium, cobalt, copper, magnesium,
manganese, iron, selenium, and zinc, and maintained and
housed at the University of Michigan following the Commit-
tee on the Care and Use of Animals guidelines (approval
#PRO00008431).22 Four animals per group were sacrificed
using pentobarbital (Vortech, Dearborn, MI) at the ages of
41, 73, 120 days, and end stage. End stage was determined
based on weight lost, limb paralysis, or lack of righting
reflexes.23 Age- and sex-matched controls were sacrificed at
the same time for each SOD1G93A mouse. Animals were
genotyped by PCR as per the supplier’s instructions. Brains
were frozen in liquid nitrogen and lower mandibles were dis-
sected for LA-ICP-MS analysis.
Metal concentrations in mouse incisors were determined at
specific locations by LA-ICP-MS (Table 1). A two-tiered sta-
tistical approach was implemented to evaluate the discrete
effects of individual elements, and to evaluate the combined
mixture effect. To address the first goal, simple linear models
were constructed to compare metal mean counts of SOD1G93A
and littermate controls while controlling for age and sex. A
logistic WQS regression model was constructed24 to evaluate
if mixture effects predicted the SOD1G93A genotype.
For murine brain metal distribution analysis, 30-µm fro-
zen brain sections from transgenic and WT mice were
qualitatively analyzed by LA-ICP-MS. A Cetac LSX 
213G2 + laser ablation unit (Teledyne Instruments, Inc.)
with 213nm Nd:YAG laser connected to an 8900 triple-quad
ICP-MS (Agilent Technologies) was used (Table 1).
Results
Participants and samples
Permanent teeth were analyzed from 36 ALS and 31 con-
trol participants (Table 2). Two cases were born in earlier





(Human/Mouse) Cetac LSX − 213G2 + (Mouse) Agilent 8900 ICP‐MS (Mouse)





0.6/0.6 Helium carrier flow (Lmin–1) 0.75 Argon carrier flow (Lmin–1) 0.55
Fluence (Jcm2) 5/3 Plasma gas
flow (Lmin–1)
15/15 Fluence (mJ) 0.05 Plasma gas flow (Lmin–1) 15
Repetition rate (Hz) 10/20 Sample
Depth (mm)
4/4 Repetition rate (Hz) 20 Sample Depth (mm) 4
Spot size (μm) 35/25 Scan mode Peak hopping Spot size (μm) 30 Scan mode Peak hopping
Scan speed (μm s–1) 35/25 Integration
time (ms)
50–55/22‐100 Scan speed (μms–1) 75 Integration time (ms) 27‐32
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decades compared to controls (Fig. S1). ALS onset was
bulbar for 13 participants (36.1%) and limb for 23 partic-
ipants (63.9%). Most (88.9%) had sporadic ALS, while
four participants were having familial ALS (fALS) – two
were positive for pathological C9orf72 GGGGCC expan-
sions, one was positive for SOD1A4V, and one had a
SOD1A4V family history of ALS. Samples were taken at
autopsy for 35 of the ALS participants, and from routine
dental extractions for all controls and one ALS partici-
pant. Sex distribution was similar for ALS and control
participants. Except for one subject of unreported ethnic-
ity, ALS participants were Caucasian, while the control
group consisted of Caucasians (83.9%), Black/African
Americans (12.9%), or other ethnicity (3.2%). Smoking
was less common in ALS participants than in controls
(50.0% of cases versus 77.4% of controls, P = 0.004). The
samples consisted of first molars (43%), followed by sec-
ond molars (24%), canines (13%), incisors (12%), pre-
molars (4%), and third molars (3%).
Critical windows of ALS case–control
divergence for individual metals
DLMs revealed a significant increase in individual metals
uptake in ALS cases versus controls and the developmen-
tal stages of maximal difference were distinct for each
metal (Fig. 1A, arrows). Chromium uptake increased after
age 10 in cases. In contrast, manganese was significantly
higher in cases from birth until approximately 6 years
and it was significantly lower between 12 and 15 years.
Nickel and tin showed discrete windows of increased
uptake in cases, from 6 to 10 years for nickel and from 0
to 2.5 years for tin. Zinc levels were significantly higher
in cases throughout the study period. Although not sig-
nificant, cases showed an increasing trend for copper
uptake between birth and 10 years and for lead from 12
to 15 years, and a decreasing trend for lithium from birth
to 15 years. At the point of maximal difference, ALS cases
had higher uptake levels than controls by 1.49 times for
chromium (95% CI, 1.11–1.82; at 15 years), 1.82 times
for manganese (95% CI, 1.34–2.46; at birth), 1.65 times
for nickel (95% CI, 1.22–2.01; at 8 years), 2.46 times for
tin (95% CI, 1.65–3.30; at 2 years), and 2.46 times for
zinc (95% CI, 1.49–3.67; at 6 years) (Fig. 1B).
Co-exposure to metal mixtures in ALS
Metals generally exist as mixtures; therefore, we examined
the contribution of multiple metals exposure during
childhood on ALS development using lagged WQS. We
found higher metal concentrations in the ALS cases dur-
ing three exposure windows (Fig. 2A). In the first expo-
sure window (0- <2 years), the 11 metals tested (barium,
chromium, copper, lithium, magnesium, manganese,
nickel, lead, tin, strontium, and zinc) showed higher
concentrations in a mixture, each metal contributing
similarly. In contrast, in the second exposure window
(7-9 years), barium, copper, lead, and zinc showed the
greatest differences. In the third exposure window (13-
15 years), barium, copper, lithium, lead, magnesium, tin,
and zinc showed the greatest differences between groups
compared to the other three components at 15 years
Table 2. Characteristics of study participants.
Characteristics ALS group (n = 36) Control group (n = 31) P-value
Age (years)(a,b,c) 63.0, 62.1  1.8, (27-87) 57.5, 55.5  2.1 (25-74) 0.0180(f)
Sex Male 17 (47.2%) 16 (51.6%) 0.808(g)
Female 19 (52.8%) 15 (48.4%) –
Onset Bulbar 13 (36.1%) – –
Limb 23 (63.9%) – –
Family history/known causative gene Yes(d) 4 (11.1%) – –
No(e) 32 (88.9%) – –
Ethnicity Caucasian 35 (97.2%) 26 (83.9%) 0.047(h)
Black/AA – 4 (12.9%) –
Other – 1 (3.2%) –
NA 1 (2.8%) 0
Tobacco Yes 18 (50.0%) 24 (77.4%) 0.004(g)
No 18 (50.0%) 4 (12.9%) –
NA – 3 (9.7%) –
(a) median; (b) mean  standard error; (c) range; (d) familial ALS was determined by known family history or genetic alterations for SOD1 or
C9orf 72; (e) one adopted participant was classified as sporadic ALS as it was negative for abnormal C9orf72 expansions; (f) Student’s t-test; (g)
Fisher’s exact test: male and female for sex, Yes and No answers for smoking; (h) Chi-squared test: Caucasian, black/AA, and other for ethnicity;
AA, African American; NA, Data not available.
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Direction of maximal 
difference
Chromium >10 15 1.49 (1.11-1.82)
Manganese 0-6, 12-15 0 1.82 (1.34-2.46)
Nickel 6-10 8 1.65 (1.22-2.01)
Tin 0-2.5 2 2.46 (1.65-3.30)
Zinc 0-15 6 2.46 (1.49-3.67)

























Figure 1. Early‐life developmental differences in metal uptake between ALS cases and controls. (A) Graphical representation of reverse DLMs.
Results were adjusted for batch, sex, age at tooth extraction, smoking history, and intra‐subject correlated observations. Significant windows of
exposure are defined as periods where the 95% piecewise CIs (grey bands) and the 95% Holm–Bonferroni family‐wise CIs (vertical bars) do not
cross zero. ALS cases, n=36; controls, n=31. The developmental stages of maximal difference are indicated by arrows. (B) Critical windows of
divergence for individual metals between cases and controls observed in (A).
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(Fig. 2B). These data indicate that: 1) overall metal dys-
regulation in ALS occurs in early childhood; however, this
effect is primarily limited to a few metals in adolescence;
2) barium, copper, lead, strontium, and zinc are the
strongest drivers associated with ALS when considered in
a mixture in late childhood and adolescence; and 3) the
effects of copper and lead are only significant with other
metal exposures (Fig. 1).
A sensitivity analysis excluding the fALS cases did not
show significant changes in the direction of metal uptake
and the maximal differences between groups when the
metals were studied individually or in a mixture (Figs. S2,
S3A). However, lead and zinc have a larger contribution
to the mixture effect between 5 and 12 years and no late
contributions (13–15 years) of copper, strontium, and
barium in mixtures were observed in the absence of the
fALS cases (Fig. S3B).
Interactive effect of metal mixtures in an
ALS mouse model
We examined tooth biomarkers in an ALS mouse model
overexpressing human mutant SOD1G93A. Element analy-
ses of murine incisors at specific ages or when studied as
a group did not identify fluctuations in metal uptake
associated with ALS, individually or in combination
(Fig. 3A, Table S1). Marginal differences were observed
for manganese (P < 0.08) and cobalt (P < 0.1). However,
WQS analysis revealed that a metal mixture is signifi-
cantly different between SOD1G93A versus WT mice
(P < 0.037). This effect is driven by manganese, cobalt,
chromium, calcium, strontium, and zinc, with smaller
contributions from other metals (Fig. 3B). The mixture
contribution of metals to disease outcome in an environ-
mentally controlled animal model of ALS may be more
meaningful than studying each metal individually.
Metal distribution in brain is altered in an
ALS mouse model
To further elucidate metal dysregulation in ALS, we visu-
alized metal spatial distribution in mouse brain sections
by LA-ICP-MS. Qualitative analysis of whole brain maps
from SOD1G93A and WT mice showed clear differences of
metal distribution. In particular, we observed increased
zinc and decreased magnesium levels in transgenic mice
compared to WT mice, especially in regions such as
the motor cortex, the prelimbic, and infralimbic areas of
the frontal cortex, and nucleus of the vertical limb of the
diagonal band. No appreciable differences were observed
with manganese between groups (Fig. 3C).
Discussion
Epidemiological and clinical evidence links metal expo-
sure to ALS risk,25 and metal deposits in teeth are stable
and reflect exposure and metal metabolism during develop-
ment. Hence, we analyzed human permanent teeth to retro-
spectively determine whether early life metal dyshomeostasis
associates with ALS. We detected increased uptake of metals
in ALS cases, including chromium, manganese, nickel, tin,
and zinc, all of which have been associated with ALS after
diagnosis.3,25 In a mixtures analysis, we identified critical
developmental windows where increased uptake of 11 metals
















































Figure 2. Co-exposure of multiple metals during childhood is
associated with ALS in adulthood. Lagged WQS analysis of 11 metals
for ALS cases (n = 36) versus controls (n = 31). (A) Weighted DLM
adjusted for batch, sex, age at tooth extraction, smoking history, and
intra-subject correlated observations, where 95% piecewise CIs of the
index (grey bands) and 95% Holm–Bonferroni family-wise CIs
adjusted for multiple comparisons (vertical bars) represent the regions
of the graph that are statistically significant. (B) Relative weights of
each metal in the mixture over time. Barium, Ba; chromium, Cr;
copper, Cu; lithium, Li; magnesium, Mg; manganese, Mn; nickel, Ni;
lead, Pb; tin, Sn; strontium, Sr; and zinc, Zn. Three developmental
exposure windows at which metal concentrations are higher in the
ALS cases compared to controls are indicated by arrows (0– <2, 7–9
and 13–15 years).
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brain biomarkers from a mouse model of fALS, which sup-
ported the mixture contribution of metals to disease out-
come. This study represents the first direct evidence showing
that early life metal dysregulation is associated with ALS
using permanent teeth as metal uptake biomarkers.
Although the etiology of ALS is unknown, metal
dyshomeostasis is linked to cellular mechanisms
dysregulated in ALS, including energy metabolism, pro-
tein control, oxidative stress, glutamate excitotoxicity,
neuroinflammation, and nucleocytoplasmic transport.26–28
We observed the uptake of essential metals that are
involved in several biological processes and are important
for the proper function of proteins encoded by
ALS-associated genes. For example, copper and zinc are
cofactors for SOD1 while manganese is a cofactor for
SOD2 and glutamine synthetase29, and altered levels and
chronic exposure to these metals lead to aggregation and
cellular mislocalization of SOD1 and transactive response
DNA binding protein 43 KDa (TDP-43).30–32 Moreover,
the redox capacity of copper increases oxidative stress,
while zinc and manganese accumulation in motor neu-
rons and astrocytes contributes to excitotoxicity.31,33,34 In
addition, overexposure to nickel results in damage to
mitochondria and alterations in cognition and locomo-
tion,35,36 while high levels of barium compromises myelin
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Figure 3. Metal dyshomeostasis in a mouse model of ALS. (A) Lower mandibles and whole brains were harvested from SOD1G93A and littermate
control mice at 47, 71, 120, and ~160 days of age (red arrows). Corresponding developmental periods in humans are indicated (top).
Morphological and physiological alterations such as neuromuscular junction dysfunction and motor skill deterioration in SOD1G93A mice develop
before disease onset. (B) LA-ICP-MS was used to determine metal concentrations in teeth and mixture analyses were performed by WQS to
identify the relative weights (importance) of each metal in the mixture when comparing transgenic to wild-type (WT) mice by groups (P = 0.037;
SOD1G93A n = 14; WT n = 15). (C) Brain distribution of biometals is altered in transgenic mice. Representative metal spatial concentration for
zinc, magnesium, and manganese by LA-ICP-MS on 30 µm anterior sections of coronal mouse brain from SODG93A and WT animals (end-of-
stage). Anatomical regions of interest are delineated. M1, primary motor cortex; M2, secondary motor cortex; PL, prelimbic area; ILA, infralimbic
area. For elemental maps, pixel size is approximately 30 9 30 µm.
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in neurodegeneration.37 Nonessential metals, including
lead and tin, also induce cellular injury by increasing
damaging reactive oxygen species and promoting mito-
chondrial dysfunction, altered energy metabolism, and
cytoplasmic TDP-43 aggregation.38,39
Humans are exposed to multiple toxic metals and
essential elements throughout life. Our results support the
growing notion that in a complex mixture of environ-
mental chemical exposures, toxicants have an additive or
synergistic effect on health outcomes.4,40,41 Moreover,
early life environmental insults are linked to predisposi-
tion to late-onset neurodegeneration.42 Therefore, our
analysis is unique as it retrospectively distinguishes devel-
opmental windows at which metal interactions may con-
tribute to ALS onset.
The dynamic interplay between metals, aging, and
genetics has been reported in fALS animal models and
autopsy tissue. Each region of the central nervous system
displays a unique normal metal pattern associated with its
function. However, copper, iron, manganese, and zinc are
redistributed and aberrantly accumulated in the central
nervous system in an age-dependent manner or in associ-
ation with ALS.43–47 The metal accumulation rate in the
motor cortex and the prefrontal cortex in ALS, for exam-
ple, may exceed the ability of antioxidant defense and
detoxification mechanisms of neurons in those regions to
cope with metal-dependent reactive oxygen species gener-
ation, and may thus contribute to impaired executive
function and conditioned fear in ALS.48
Our sensitivity analysis yields interesting insights, espe-
cially when considered within the context of toxicant–
gene interactions and the multistep ALS model.2,49 Lead
and zinc are strongly associated with sALS in a mixture
analysis between the ages of 5 and 12 years, while barium,
copper, and strontium are less so. Metals may also influ-
ence disease outcome differently based on an individual’s
genetic background. A person with sALS may be more
influenced by lead and zinc in mid-childhood, whereas
those with fALS may be impacted by other metals, such
as barium, copper, and strontium in mid-adolescence. In
this study, our small sample size limited us from explor-
ing metal-by-metal and metal-by-genotype interactions.
Nonetheless, considering that our mouse model, con-
tained within a highly controlled environment, also shows
a contribution of metals to ALS risk, it does give credence
to our findings in humans. Metal dyshomeostasis in tooth
biomarkers from SOD1G93A mice provides a powerful tool
to identify adverse environmental and genetic factors
associated with molecular mechanisms triggering metal
dyshomeostasis in ALS.
Although restoration of metal homeostasis provides
promising results as ALS therapeutics,45,50 early interven-
tions may be more effective and preventative. It is becom-
ing clear that metal–gene interactions are linked to
predisposition to metal toxicity and disease; however,
early life metal–gene interactions in ALS are still not com-
pletely understood. This is likely due to lack of early life
biomarkers, complex and unknown disease etiology, and
statistical methodology limitations.51 The present work
also opens up further questions: (1) what are the mecha-
nisms leading to early life metal dyshomeostasis and
abnormal cellular distribution? and (2) how and when do
early life metal–gene interactions associated with ALS risk
take place? In other words, can we differentiate whether
Age
(years)10 20 50 7030 40 60 80
Latency 
period
Accumulation of metals in neuronal tissue
Altered epigenetics












Figure 4. Proposed framework of metal exposure and the development of ALS. In ALS, metal dyshomeostasis may be influenced by genetic
mutations (SOD1, TDP-43, C9orf72, genetic modifiers) (orange circle) and/or exposure to environmental toxicants (blue circles) during the prenatal
and childhood periods (susceptible period). Alterations in biological pathways and epigenetic mechanisms associated with ALS pathology in
addition to exposure to other environmental factors (purple circle) in early adulthood (latency period) and aging may be pathological triggers or
mediators of ALS onset and progression later in life.
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metal dyshomeostasis increases ALS risk or whether other
factors leading to ALS predispose individuals to an aber-
rant metal accumulation?
As ALS is a late-onset disease, and in many cases,
teeth have been extensively restored or are absent at the
time of death, obtaining preserved permanent teeth from
ALS and control participants is challenging and limits
sample size. Despite our small cohort size, our novel
tooth-matrix biomarkers and stringent statistical methods
increased our power to detect statistically significant
findings in multivariable-adjusted models after control-
ling for any significant difference between groups. Of
note, our cohort consisted of mostly Michigan residents
and may restrict the generalizability of our findings, so
validation in a larger cohort is needed. Furthermore, LA-
ICP-MS is not the ideal method for measuring other ele-
ments in teeth, such as aluminum, fluoride, iron, and
mercury, preventing us from studying their impact on
ALS. As tooth-matrix biomarkers represent a new
methodology, future studies will yield insight into alter-
ations from racial/ethnic differences, lifetime smoking
exposure, and geographical locations. Our study’s obser-
vational design cannot confirm causation, and other
interacting exposome and genetic factors, as well as
metal uptake and metabolism may contribute to adverse
health outcomes.40
Overall, identifying causative links between early life
metal uptake and late-onset neurodegeneration is chal-
lenging. However, our results support the gene-time-envi-
ronment and multiple hit hypotheses by showing an
association between early life metal dysregulation and
ALS in different developmental windows, as well as joint
effects of co-exposure to multiple metals2,42,52 (Fig. 4).
These effects may contribute to various pathologic alter-
ations in cells that induce a fragile state in motor neurons
during development and increase susceptibility to prema-
ture damage of neurons and supporting nonneuronal
cells. Environmental and occupational exposures during
early adulthood in combination with aging may then trig-
ger ALS onset.52 Hence, while more studies are needed,
the current data support the link between early life
adverse systemic elemental dysregulation and adult-onset
neurodegeneration.
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Figure S1. ALS cases and control participants were born
in similar decades. Bar plot representing frequency distri-
bution of birth decades for all cases versus controls was
generated using Tableau. ALS cases, n = 36; controls,
n = 31.
Figure S2. Early life developmental differences in metal
uptake between sporadic ALS cases and controls. Reverse
DLMs were adjusted for batch, sex, age at tooth extrac-
tion, smoking history, and intra-subject correlated obser-
vations. Sensitivity analysis removing fALS samples
indicated similar trends of metal uptake as when all the
samples are included in the analysis (see Fig. 1). Sporadic
ALS, n = 32 and controls, n = 31. Developmental expo-
sure windows, arrows.
Figure S3. Sensitivity analysis of uptake and contribution
of metals to sporadic ALS when analyzed as a mixture at
specific developmental windows. Sensitivity analysis of
lagged WQS of 11 metals for sporadic ALS cases (n = 32)
versus controls (n = 31). (A) Weighted DLM adjusted for
batch, sex, age at tooth extraction, smoking history, and
intra-subject correlated observations (95% piecewise CIs
of the index, tan bands and 95% Holm–Bonferroni fam-
ily-wise CIs adjusted for multiple comparisons, vertical
bars). (B) Relative weights of each metal in the mixture
over time. Barium, Ba; chromium, Cr; copper, Cu;
lithium, Li; magnesium, Mg; manganese, Mn; nickel, Ni;
lead, Pb; tin, Sn; strontium, Sr; and zinc, Zn. Develop-
mental exposure windows, arrows.
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